SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-008898
Filing Date
2023-12-18
Accepted
2023-12-15 18:14:03
Documents
15
Period of Report
2023-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 33183
2 EQUITY DISTRIBUTION AGREEMENT, BY AND BETWEEN SONOMA PHARMACEUTICALS, INC. AND M sonoma_ex0101.htm EX-1.1 252158
3 OPINION AND CONSENT OF BURNS & LEVINSON, LLP sonoma_ex0501.htm EX-5.1 12555
7 GRAPHIC image_001.jpg GRAPHIC 15515
  Complete submission text file 0001683168-23-008898.txt   560536

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snoa-20231215.xsd EX-101.SCH 3027
5 XBRL LABEL FILE snoa-20231215_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE snoa-20231215_pre.xml EX-101.PRE 22367
9 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3299
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 231491730
SIC: 2834 Pharmaceutical Preparations